Go Pro

Integra LifeSciences (IART) Short Interest Ratio & Short Volume

Integra LifeSciences logo
$17.12 -0.13 (-0.75%)
As of 09:31 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Integra LifeSciences Short Interest Overview

As of July 15, 2026, Integra LifeSciences (IART) had a short interest of 6.21 million shares sold short, representing 8.29% of the public float. This marks a -2.96% decrease in short interest since the prior report. The short interest ratio (days to cover) is 7.2, meaning it would take 7.2 days of the average trading volume of 902,849 shares to cover all short positions.

Current Short Interest
6,205,140 shares
Previous Short Interest
6,394,225 shares
Change Vs. Previous Month
-2.96%
Dollar Volume Sold Short
$116.53 million
Short Interest Ratio
7.2 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
77,770,000 shares
Short Percent of Float
8.29%
Today's Trading Volume
519 shares
Average Trading Volume
902,849 shares
Today's Volume Vs. Average
0%
Short Selling Integra LifeSciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Integra LifeSciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

IART Short Interest Over Time

IART Days to Cover Over Time

IART Percentage of Float Shorted Over Time

Integra LifeSciences Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20266,205,140 shares $116.53 million -3.0%8.3%7.17 $18.78
6/30/20266,394,225 shares $114.84 million -11.4%8.5%5.71 $17.96
6/15/20267,215,990 shares $125.99 million -9.6%9.6%8.65 $17.46
5/29/20267,985,286 shares $128.08 million -13.2%10.7%8.08 $16.04
5/15/20269,202,128 shares $129.75 million -1.4%12.3%6.08 $14.10
4/30/20269,328,293 shares $98.32 million +1.8%12.5%12.59 $10.54
4/15/20269,160,085 shares $101.04 million +3.4%12.2%12.05 $11.03
3/31/20268,857,998 shares $83.44 million +6.0%11.8%10.5 $9.42
3/13/20268,359,840 shares $77.24 million +11.8%11.1%9.31 $9.24
2/27/20267,477,175 shares $85.09 million -1.5%9.9%9.75 $11.38
2/13/20267,588,606 shares $85.90 million -0.6%10.1%10.77 $11.32
1/30/20267,631,554 shares $85.02 million +2.7%10.2%10.77 $11.14
1/15/20267,430,637 shares $94.00 million +0.8%9.9%10.92 $12.65
12/31/20257,369,471 shares $91.53 million +7.1%9.8%10.33 $12.42
12/15/20256,881,446 shares $92.69 million +3.4%9.2%8.56 $13.47
11/28/20256,653,021 shares $87.22 million +1.9%8.9%7.46 $13.11
11/14/20256,529,500 shares $76.72 million -5.3%8.7%5.69 $11.75
10/31/20256,896,541 shares $82.83 million +3.1%9.2%5.18 $12.01
10/15/20256,690,000 shares $95.20 million +7.2%10.2%5.5 $14.23
9/30/20256,240,000 shares $89.42 million -2.8%9.5%5.1 $14.33
9/15/20256,420,000 shares $96.75 million -10.7%9.8%5.1 $15.07
8/31/20257,190,000 shares $108.78 million -1.4%10.9%5.4 $15.13
8/15/20257,290,000 shares $103.45 million +6.6%11.1%5.7 $14.19
7/31/20256,840,000 shares $89.88 million +5.7%10.4%5.3 $13.14
7/15/20256,470,000 shares $75.96 million -3.0%9.9%5 $11.74
6/30/20256,670,000 shares $81.84 million +9.0%10.2%5.3 $12.27
6/15/20256,120,000 shares $74.42 million +13.8%9.3%5.2 $12.16
5/31/20255,380,000 shares $68.54 million +11.4%8.2%5.1 $12.74
5/15/20254,830,000 shares $62.84 million +26.8%7.4%4.6 $13.01
4/30/20253,810,000 shares $62.45 million +10.1%5.7%4.1 $16.39
4/15/20253,460,000 shares $55.64 million +4.5%5.2%5 $16.08
3/31/20253,310,000 shares $72.79 million -16.8%5.0%4.9 $21.99
3/15/20253,980,000 shares $88.95 million +1.8%6.0%6.1 $22.35
2/28/20253,910,000 shares $90.75 million +11.7%5.9%6.2 $23.21
2/15/20253,500,000 shares $84.63 million +2.9%5.3%5.7 $24.18
1/31/20253,400,000 shares $88.74 million +0.9%5.2%5.3 $26.10
1/15/20253,370,000 shares $75.56 million +4.0%5.1%4.6 $22.42
12/31/20243,240,000 shares $73.48 million -6.1%4.9%4.1 $22.68
12/15/20243,450,000 shares $82.90 million +1.5%5.2%4.2 $24.03
11/30/20243,400,000 shares $83.57 million -17.1%5.1%3.6 $24.58
Why Trump really wants Greenland (Ad)

The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar.tc pixel

Watch the full documentary before December's economic summit in Miami
11/15/20244,100,000 shares $93.81 million -20.9%6.2%4.2 $22.88
10/31/20245,180,000 shares $97.18 million +1.4%8.0%5.5 $18.76
10/15/20245,110,000 shares $99.70 million +16.1%7.9%4.6 $19.51
9/30/20244,400,000 shares $79.95 million -3.7%6.8%3.9 $18.17
9/15/20244,570,000 shares $79.84 million -5.0%7.0%3.5 $17.47
8/31/20244,810,000 shares $97.84 million +0.4%7.4%3.1 $20.34
8/15/20244,790,000 shares $104.71 million +8.9%7.4%3.1 $21.86
7/31/20244,400,000 shares $109.16 million +6.5%6.7%2.7 $24.81
7/15/20244,130,000 shares $123.24 million +32.0%6.2%2.6 $29.84
6/30/20243,130,000 shares $91.21 million -10.8%4.7%2 $29.14
6/15/20243,510,000 shares $102.67 million -12.0%5.3%2.5 $29.25
5/31/20243,990,000 shares $123.29 million +59.6%6.0%3.6 $30.90
5/15/20242,500,000 shares $66.18 million +2.0%3.8%2.3 $26.47
4/30/20242,450,000 shares $71.47 million -6.1%3.7%2.5 $29.17
4/15/20242,610,000 shares $83.68 million +24.9%4.0%3.6 $32.06
3/31/20242,090,000 shares $74.09 million -5.4%3.2%3.2 $35.45
3/15/20242,210,000 shares $76.69 million -12.0%3.3%3.6 $34.70
2/29/20242,510,000 shares $92.64 million +0.8%3.8%4.2 $36.91
2/15/20242,490,000 shares $111.43 million +7.8%3.8%4.7 $44.75
1/31/20242,310,000 shares $92.75 million +6.5%3.5%4.5 $40.15
1/15/20242,170,000 shares $93.18 million +4.3%3.3%3.7 $42.94
12/31/20232,080,000 shares $90.58 million -10.3%3.1%3.3 $43.55
12/15/20232,320,000 shares $99.23 million -3.7%3.5%3.7 $42.77
11/30/20232,410,000 shares $94.45 million -0.8%3.6%3.8 $39.19
11/15/20232,430,000 shares $95.55 million +4.7%3.7%3.9 $39.32
10/31/20232,320,000 shares $83.43 million -2.9%3.4%3.7 $35.96
10/15/20232,390,000 shares $91.47 million -5.5%3.4%3.7 $38.27
9/30/20232,530,000 shares $96.62 million +4.6%3.6%4 $38.19
9/15/20232,420,000 shares $95.90 million -5.8%3.4%3.8 $39.63
8/31/20232,570,000 shares $109.33 million -9.2%3.6%3.9 $42.54
8/15/20232,830,000 shares $123.22 million +17.9%4.0%3.5 $43.54
7/31/20232,400,000 shares $109.13 million +20.6%3.4%3 $45.47
7/15/20231,990,000 shares $85.49 million -5.2%2.9%2.6 $42.96
6/30/20232,100,000 shares $86.37 million -6.7%3.0%2.9 $41.13
6/15/20232,250,000 shares $92.86 million -1.3%3.2%3.3 $41.27
5/31/20232,280,000 shares $86.53 million -22.2%3.3%3.5 $37.95
5/15/20232,930,000 shares $144.74 million -20.6%4.1%4.7 $49.40
4/30/20233,690,000 shares $204.13 million +16.0%5.2%7.1 $55.32
4/15/20233,180,000 shares $187.56 million -9.1%4.5%6.9 $58.98
3/31/20233,500,000 shares $200.94 million -9.1%4.9%7.5 $57.41
3/15/20233,850,000 shares $204.40 million -19.3%5.4%8.1 $53.09
2/28/20234,770,000 shares $265.31 million -12.2%6.7%9.7 $55.62
2/15/20235,430,000 shares $313.96 million -7.8%7.5%11.7 $57.82
1/31/20235,890,000 shares $337.50 million +53.0%8.1%13.1 $57.30
1/15/20233,850,000 shares $220.99 million -3.8%5.3%7.4 $57.40
12/30/20224,000,000 shares $224.28 million -0.3%5.5%7.1 $56.07
12/15/20224,010,000 shares $226.00 million -2.2%5.5%6.8 $56.36
11/30/20224,100,000 shares $225.25 million -5.5%5.7%7 $54.94
11/15/20224,340,000 shares $233.88 million +0.7%6.0%7.1 $53.89
10/31/20224,310,000 shares $216.58 million +5.9%5.9%7.3 $50.25
Why Trump really wants Greenland (Ad)

The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar.tc pixel

Watch the full documentary before December's economic summit in Miami
10/15/20224,070,000 shares $171.63 million +2.0%5.6%7.5 $42.17
9/30/20223,990,000 shares $169.02 million -0.3%5.5%8.1 $42.36
9/15/20224,000,000 shares $190.32 million +1.3%5.5%7.9 $47.58
8/31/20223,950,000 shares $188.45 million -7.7%5.5%7.9 $47.71
8/15/20224,280,000 shares $243.19 million +0.7%5.9%9 $56.82
7/31/20224,250,000 shares $233.92 million -2.8%5.9%9.1 $55.04
7/15/20224,370,000 shares $231.65 million +6.9%6.1%8.8 $53.01
6/30/20224,090,000 shares $220.98 million +3.5%5.7%8.7 $54.03
6/15/20223,950,000 shares $222.90 million -3.0%5.5%8.4 $56.43
5/31/20224,070,000 shares $254.94 million -1.7%5.7%8.8 $62.64
5/15/20224,140,000 shares $245.58 million -7.6%5.7%8.4 $59.32
4/30/20224,480,000 shares $274.00 million -1.3%6.2%8.8 $61.16
4/15/20224,540,000 shares $284.57 million -0.2%6.3%9.6 $62.68
3/31/20224,550,000 shares $292.38 million -0.2%6.3%9.5 $64.26
3/15/20224,560,000 shares $295.94 million -4.2%6.3%10.4 $64.90
2/28/20224,760,000 shares $319.21 million -0.4%6.6%11.3 $67.06
2/15/20224,780,000 shares $319.64 million -8.8%6.5%11.8 $66.87
1/31/20225,240,000 shares $339.24 million -8.4%7.1%13.9 $64.74
1/15/20225,720,000 shares $393.48 million +17.9%7.8%15.4 $68.79
12/31/20214,850,000 shares $324.90 million -1.4%6.6%13.8 $66.99
12/15/20214,920,000 shares $316.26 million +0.2%6.7%13.9 $64.28
11/30/20214,910,000 shares $313.99 million +8.6%6.7%14.1 $63.95
11/15/20214,520,000 shares $309.12 million -0.4%6.2%13.2 $68.39
10/29/20214,540,000 shares $301.73 million -7.9%6.2%12.9 $66.46
10/15/20214,930,000 shares $333.66 million +11.5%6.8%13.5 $67.68
9/30/20214,420,000 shares $302.68 million +1.8%6.1%11.7 $68.48
9/15/20214,340,000 shares $300.63 million -2.9%5.9%11.4 $69.27
8/31/20214,470,000 shares $336.28 million -9.3%6.1%12.4 $75.23
8/13/20214,930,000 shares $350.18 million +5.6%6.8%13.7 $71.03

IART Short Interest - Frequently Asked Questions

Short interest is the volume of Integra LifeSciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 6,205,140 shares of IART short. 8.29% of Integra LifeSciences' shares are currently sold short. Learn More on Integra LifeSciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IART shares currently have a short interest ratio of 7.2. Learn More on Integra LifeSciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.29% of Integra LifeSciences' floating shares are currently sold short.

Integra LifeSciences saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 6,205,140 shares, a decline of 3.0% from the previous total of 6,394,225 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

8.29% of Integra LifeSciences' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare equipment" compare to Integra LifeSciences: MiniMed Group Inc (2.26%), LivaNova PLC (7.47%), Integer Holdings Corporation (12.96%), iRhythm Technologies (10.54%), Haemonetics Corporation (6.07%), TransMedics Group, Inc. (23.98%), Establishment Labs Holdings Inc. (16.93%), Pulse Biosciences, Inc (16.06%), AxoGen, Inc. (10.49%), LeMaitre Vascular, Inc. (6.99%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling IART is an investing strategy that aims to generate trading profit from Integra LifeSciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Integra LifeSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IART, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IART, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IART:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:IART) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners